Sneller, Michael C.
Blazkova, Jana http://orcid.org/0000-0002-6000-202X
Justement, J. Shawn
Shi, Victoria
Kennedy, Brooke D.
Gittens, Kathleen
Tolstenko, Jekaterina
McCormack, Genevieve http://orcid.org/0000-0002-9486-0065
Whitehead, Emily J.
Schneck, Rachel F.
Proschan, Michael A.
Benko, Erika
Kovacs, Colin
Oguz, Cihan
Seaman, Michael S.
Caskey, Marina http://orcid.org/0000-0003-1727-8693
Nussenzweig, Michel C. http://orcid.org/0000-0003-0592-8564
Fauci, Anthony S.
Moir, Susan
Chun, Tae-Wook http://orcid.org/0000-0001-5153-7340
Article History
Received: 25 October 2021
Accepted: 25 April 2022
First Online: 1 June 2022
Competing interests
: M.C.N. is listed as an inventor for patents on 3BNC117 (PTC/US2012/038400) and 10-1074 (PTC/US2013/065696); 3BNC117 and 10-1074 are licensed to Gilead Sciences by Rockefeller University from which M.C.N. has received payments. M.C.N. is a member of the Scientific Advisory Boards of Celldex Therapeutics, Walking Fish Therapeutics and Frontier Biotechnologies. M.C.N. had no control over the direction and ultimately the reporting of the clinical portion of the research while holding their financial interests. The other authors declare no competing interests.
Free to read: This content has been made available to all.